These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7294115)

  • 1. Frequency of timolol administration.
    Yalon M; Urinowsky E; Rothkoff L; Treister G; Blumenthal M
    Am J Ophthalmol; 1981 Oct; 92(4):526-9. PubMed ID: 7294115
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative studies of initial pressure reduction using 0.3% metipranolol and 0.25% timolol in eyes with wide-angle glaucoma].
    Merté HJ; Stryz JR; Mertz M
    Klin Monbl Augenheilkd; 1983 Apr; 182(4):286-9. PubMed ID: 6134861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short term effects of timolol in chronic glaucoma. A double blind study using computerized perimetry.
    Holmin C; Krakau CE
    Acta Ophthalmol (Copenh); 1982 Jun; 60(3):337-46. PubMed ID: 7136544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blind randomised non-crossover long-term trial comparing topical timolol 0.25% with timolol 0.5% in the treatment of simple chronic glaucoma.
    Mills KB
    Br J Ophthalmol; 1983 Apr; 67(4):216-9. PubMed ID: 6338905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of oculo-pression-tonometry in the determination of outflow resistance].
    Ulrich C; Ulrich WD; Neunhöffer E; Fuhrmann P
    Fortschr Ophthalmol; 1987; 84(4):377-9. PubMed ID: 3666634
    [No Abstract]   [Full Text] [Related]  

  • 6. Timolol, dose response and duration of action.
    Zimmerman TJ; Kaufman HE
    Arch Ophthalmol; 1977 Apr; 95(4):605-7. PubMed ID: 322649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive intraocular pressure reduction effect of fixed combination of maleate timolol 0.5%/dorzolamide 2% (Cosopt) on monotherapy with latanoprost (Xalatan) in patients with elevated intraocular pressure: a prospective, 4-week, open-label, randomized, controlled clinical trial.
    Hatanaka M; Reis A; Sano ME; Susanna R
    J Glaucoma; 2010; 19(5):331-5. PubMed ID: 19730119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical evaluation of the effects of topically applied levobunolol and timolol on increased intraocular pressure.
    Duzman E; Ober M; Scharrer A; Leopold IH
    Am J Ophthalmol; 1982 Sep; 94(3):318-27. PubMed ID: 6751091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of orally and topically administered beta blockers for chronic simple glaucoma.
    Williamson J; Young JD; Atta H; Muir G; Kadom H
    Br J Ophthalmol; 1985 Jan; 69(1):41-5. PubMed ID: 2856893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect on diurnal intraocular pressure of the fixed combination of latanoprost 0.005% and timolol 0.5% administered in the evening in glaucoma.
    Polo V; Larrosa JM; Ferreras A; Borque E; Pablo LE; Honrubia FM
    Ann Ophthalmol (Skokie); 2008; 40(3-4):157-62. PubMed ID: 19230353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [2 years' administration of timolol to patients with chronic open-angle glaucoma].
    Novakovic A; Vujosevic E; Alajbegovic R; Hodzic S
    Bull Soc Ophtalmol Fr; 1982 Mar; 82(3):311-2. PubMed ID: 7116526
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma.
    Konstas AG; Maltezos AC; Gandi S; Hudgins AC; Stewart WC
    Am J Ophthalmol; 1999 Jul; 128(1):15-20. PubMed ID: 10482089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2).
    Serle JB; Katz LJ; McLaurin E; Heah T; Ramirez-Davis N; Usner DW; Novack GD; Kopczynski CC;
    Am J Ophthalmol; 2018 Feb; 186():116-127. PubMed ID: 29199013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin-treated glaucoma patients.
    Aihara M; Adachi M; Matsuo H; Togano T; Fukuchi T; Sasaki N;
    Acta Ophthalmol; 2017 Dec; 95(8):e720-e726. PubMed ID: 28371482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined timolol and pilocarpine vs pilocarpine alone and timolol alone in the treatment of glaucoma.
    Zadok D; Geyer O; Zadok J; Lazar M; Krakowski D; Nemet P
    Am J Ophthalmol; 1994 Jun; 117(6):728-31. PubMed ID: 8198156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual field survival: the response to timolol therapy in open-angle glaucoma.
    Sponsel WE; Dallas NL; Burbridge L
    Br J Ophthalmol; 1983 Apr; 67(4):220-7. PubMed ID: 6830740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and safety of timoptic depot in hypotensive therapy of glaucoma].
    Erichev VP; Iakubova LV
    Vestn Oftalmol; 1998; 114(1):8-9. PubMed ID: 9584629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separate and combined effects of timolol maleate and acetazolamide in open-angle glaucoma.
    Berson FG; Epstein DL
    Am J Ophthalmol; 1981 Dec; 92(6):788-91. PubMed ID: 7315930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the beta-adrenergic receptor-binding agent 'timolol' in the treatment of open-angle glaucoma.
    Strempel I
    Ophthalmologica; 1982; 184(4):198-203. PubMed ID: 6122193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.